An analysis of surveillance for stage I combined teratoma - seminoma of the testis
1996

Analysis of Stage I Testicular Tumors

Sample size: 973 publication Evidence: moderate

Author Information

Author(s): R Thomas, D Dearnaley, J Nicholls, A Norman, S Sampson, A Horwich

Primary Institution: The Royal Marsden NHS Trust

Hypothesis

Do combined teratoma-seminoma tumors have a different natural history compared to pure seminoma and non-seminomatous germ cell tumors?

Conclusion

Patients with combined teratoma-seminoma tumors have similar outcomes to those with non-seminomatous germ cell tumors when managed with surveillance.

Supporting Evidence

  • Patients with combined tumors had a 5-year relapse-free survival of 71%, similar to NSGCT patients at 69.5%.
  • Statistical analysis showed significant differences in relapse patterns between seminoma and the other two groups.
  • Over 90% of seminoma relapses occurred in abdominal nodes, compared to 46% for combined tumors.

Takeaway

This study looked at boys with testicular tumors and found that those with a mix of tumor types do just as well as those with only one type when watched closely after surgery.

Methodology

The study analyzed 973 patients with stage I testicular tumors, comparing age at presentation and outcomes for those with combined tumors, non-seminomatous germ cell tumors, and seminoma.

Potential Biases

There was no selection bias as patients managed by surveillance were representative of the entire patient population.

Limitations

The study is limited to patients referred to a single institution and may not be generalizable.

Participant Demographics

Median ages at presentation were 27 years for NSGCT, 33 years for combined tumors, and 36 years for seminoma.

Statistical Information

P-Value

P=0.01

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication